| One year in review 2019: pathogenesis of rheumatoid arthritis C Croia, R Bursi, D Sutera, F Petrelli, A Alunno, I Puxeddu Clin Exp Rheumatol 37 (3), 347-357, 2019 | 255 | 2019 |
| COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy C Perricone, E Bartoloni, R Bursi, G Cafaro, GM Guidelli, Y Shoenfeld, ... Immunologic research 68, 213-224, 2020 | 234 | 2020 |
| The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 C Perricone, P Triggianese, E Bartoloni, G Cafaro, AF Bonifacio, R Bursi, ... Journal of Autoimmunity 111, 102468, 2020 | 154 | 2020 |
| Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases M Gatto, C Perricone, M Tonello, O Bistoni, AM Cattelan, R Bursi, ... Clin Exp Rheumatol 38 (4), 754-759, 2020 | 78 | 2020 |
| One year in review 2021: Sjögren’s syndrome G Cafaro, R Bursi, LG Chatzis, G Fulvio, F Ferro, E Bartoloni, C Baldini Clin Exp Rheumatol 39 (Suppl 133), S3-13, 2021 | 36 | 2021 |
| Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections C Perricone, P Triggianese, R Bursi, G Cafaro, E Bartoloni, MS Chimenti, ... Microorganisms 9 (1), 121, 2021 | 35 | 2021 |
| Contribution of janus-kinase/signal transduction activator of transcription pathway in the pathogenesis of vasculitis: a possible treatment target in the upcoming future R Bursi, G Cafaro, C Perricone, I Riccucci, S Calvacchi, R Gerli, ... Frontiers in Pharmacology 12, 635663, 2021 | 25 | 2021 |
| Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren’s syndrome and rheumatoid arthritis G Cafaro, C Perricone, I Riccucci, R Bursi, S Calvacchi, A Alunno, ... Clin Exp Rheumatol 39 (Suppl 133), 107-13, 2021 | 10 | 2021 |
| Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica C Perricone, G Cafaro, E Fiumicelli, R Bursi, D Bogdanos, I Riccucci, ... Clinical and Experimental Medicine 23 (7), 3391-3397, 2023 | 4 | 2023 |
| Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience L La Barbera, C Rizzo, F Camarda, F Atzeni, G Miceli, ABM Colella, ... Clinical and Experimental Rheumatology 42, 991-998, 2024 | 2 | 2024 |
| Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren’s syndrome: an inter-system reproducibility study G Cafaro, C Perricone, R Bursi, I Riccucci, S Calvacchi, G Lomurno, ... Clinical and Experimental Rheumatology 40 (12), 2253-2257, 2022 | 1 | 2022 |
| POS0025 COMBINED NAILFOLD CAPILLAROSCOPY AND ULTRASONOGRAPHY OF THE NAIL-ENTHESIS COMPLEX TO DISCRIMINATE PSORIATIC DISEASE FROM RHEUMATOID ARTHRITIS PATIENTS AND HEALTHY SUBJECTS G Cafaro, V Venerito, V Valentini, R Bursi, C Perricone, R Gerli, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 218-219, 2023 | | 2023 |
| POS0788 DISTINCT CYTOKINE/CHEMOKINE PROFILE IN SJÖGREN’S SYNDROME IS ASSOCIATED WITH DISEASE ACTIVITY AND CLINICAL MANIFESTIONS C Perricone, R Bursi, G Cafaro, R Ilenia, S Calvacchi, E Marcucci, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 681-682, 2022 | | 2022 |
| POS0019 PREDICTORS OF SUSTAINED 6 MONTHS REMISSION AND FLARE IN PATIENTS WITH POLYMYALGIA RHEUMATICA C Perricone, E Fiumicelli, G Cafaro, R Bursi, R Ilenia, EB Bocci, R Gerli Annals of the Rheumatic Diseases 80 (Suppl 1), 211-211, 2021 | | 2021 |
| CONTRIBUTION OF JAK/STAT PATHWAY IN THE PATHOGENESIS OF VASCULITIS: A POSSIBLE TREATMENT TARGET IN THE UPCOMING FUTURE R Bursi, G Cafaro, C Perricone, I Riccucci, S Calvacchi, R Gerli, ... Frontiers in Pharmacology 12, 456, 2021 | | 2021 |
